Yahoo Web Search

Search results

1. • Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting

     Digital Journal· 5 days ago

     Lee MD Abstract: #LBA9512: Individualized neoantigen therapy mRNA-4157 (V940) plus pembrolizumab in resected melanoma: 3-year update from the mRNA-4157-P201 (KEYNOTE-942) ...

2. • Small Business - Cordele Dispatch | Cordele Dispatch

     Cordele Dispatch· 4 days ago

     - Once every 3-week dosing of SNS-101 demonstrates initial signs of promising clinical activity - - Pharmacokinetic and safety profile validate conditionally active approach - - Investor webcast to be held on Monday, June 3 at 8:00

3. • 

     Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?

     Benzinga via Yahoo Finance· 3 days ago

     Thursday, Merus N.V. (NASDAQ:MRUS) announced the publication of an abstract regarding petosemtamab...

4. • TME Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders

     Morningstar· 18 hours ago

     TME Pharma N.V. (Euronext Growth Paris: ALTME) (Paris:ALTME),a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

5. • 

     Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise

     Newswise· 5 days ago

     Clinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...

6. • 

     Tumor mutations may not predict response to immuno | Newswise

     Newswise· 6 days ago

     May 22, 2024 – The number of mutations in the DNA of cancerous tumors may not be an indicator of how...

7. • Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual...

     WROC Rochester· 4 days ago

     Lilly will also host an investor event to provide an update on its oncology strategy and pipeline.

8. • Tumor mutations may not predict response to immunotherapy, study finds

     Medical Xpress· 4 days ago

     The findings, published in Nature Cancer, upend long-held conventional wisdom and could lead to more effective ways of deciding which patients will benefit most from this type of treatment.

9. • Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting

     Morningstar· 6 days ago

     Moderna to host an investor event via webcast on Monday, June 3 at 6:15 PM CDTCAMBRIDGE, MA / ACCESSWIRE / May 22, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on ...

10. • Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent...

      FOX21 Colorado Springs· 4 days ago

      The webcast will include an in-depth review of the PRGN-2012 pivotal data and business update.